Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-26 Sale | 2024-08-28 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director | 83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) | View |
| 2024-08-21 Sale | 2024-08-23 6:41 pm | ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director | 868,682 | $13.24 | $11,497,963 | 8,372,205 (Indirect) | View |
| 2024-01-23 Purchase | 2024-01-25 4:32 pm | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 454,545 | $11 | $4,999,995 | 14,756,096 (Indirect) | View |
| 2023-12-27 Sale | 2023-12-29 4:20 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director | 1,546,347 | $18.54 | $28,671,734 | 264,315 (Indirect) | View |
| 2023-08-29 Purchase | 2023-08-31 5:18 pm | ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director | 500,000 | $6.2 | $3,100,000 | 9,240,887 (Indirect) | View |
| 2022-09-16 Purchase | 2022-09-16 4:34 pm | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 484,496 | $10.32 | $4,999,999 | 14,301,551 (Indirect) | View |
| 2022-05-18 Purchase | 2022-05-20 4:32 pm | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 138,000 | $7.21 | $994,980 | 13,817,055 (Indirect) | View |
| 2021-12-29 Sale | 2021-12-30 8:55 pm | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director | 40,400 | $20.3 | $820,120 | 231,098 (Indirect) | View |
| 2021-12-21 Sale | 2021-12-23 4:08 pm | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director | 119,400 | $19 | $2,268,600 | 234,798 (Indirect) | View |
| 2021-12-16 Sale | 2021-12-17 5:16 pm | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director | 393,300 | $19.07 | $7,500,231 | 245,898 (Indirect) | View |
| 2021-09-20 Sale | 2021-09-22 5:24 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 1,109,644 | $6.09 | $6,757,732 | 6,943,654 (Indirect) | View |
| 2021-09-17 Purchase | 2021-09-21 6:38 pm | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director 10% Owner | 1,010,637 | $9.4 | $9,499,988 | 425,531 (Indirect) | View |
| 2021-06-15 Purchase | 2021-06-16 6:20 pm | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director | 705,853 | $17 | $11,999,501 | 282,398 (Indirect) | View |
| 2021-03-30 Purchase | 2021-03-31 7:11 pm | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 359,375 | $16 | $5,750,000 | 13,359,456 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-24 5:00 pm | N/A 2034-06-19 | ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:41 pm | N/A 2034-06-13 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-12 7:33 pm | 2025-06-10 2034-06-10 | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 20,594 | $0 | 20,594 (Direct) | View |
| 2024-05-20 Disposition | 2024-05-20 8:09 pm | N/A 2028-01-01 | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director | 68,100 | $0 | 0 (Direct) | View |
| 2024-05-18 Equity Swap | 2024-05-20 8:09 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director | 2,680,496 | $0 | 0 (Indirect) | View |
| 2024-01-11 Exercise | 2024-01-16 4:36 pm | 2019-01-18 2024-01-18 | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director | 145,251 | $0 | 2,680,496 (Indirect) | View |
| 2024-01-11 Exercise | 2024-01-16 4:36 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director | 145,251 | $12.74 | 2,680,496 (Indirect) | View |
| 2024-01-02 Option Award | 2024-01-04 7:02 pm | N/A 2034-01-01 | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 4:02 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-28 9:00 pm | N/A 2033-06-26 | ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:03 pm | N/A 2033-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:29 pm | 2024-06-12 2033-06-12 | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 22,123 | $0 | 22,123 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 7:07 pm | N/A 2033-01-02 | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:47 pm | N/A 2032-08-11 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 7:17 pm | 2023-06-08 2032-06-24 | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 42,087 | $0 | 42,087 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 6:54 pm | N/A 2032-06-16 | Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:35 pm | N/A 2032-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:35 pm | N/A 2032-06-13 | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 7:52 pm | N/A 2032-06-09 | Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 5:19 pm | N/A 2032-01-02 | ALPINE IMMUNE SCIENCES INC. | ALPN | Thompson Peter A. Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-04 Option Award | 2021-09-21 5:14 pm | N/A 2031-06-03 | Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:53 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 8,068,298 (Direct) | View |
| 2021-06-15 Conversion | 2021-06-16 6:20 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director | 4,161,198 | $0 | 282,398 (Indirect) | View |
| 2021-06-15 Option Award | 2021-06-16 4:15 pm | N/A 2031-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 8,068,298 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:43 pm | N/A 2031-06-09 | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2021-06-10 7:22 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Thompson Peter A. Director | 0 | $0 | 2,336,911 (Indirect) | View |
| 2022-06-02 Option Award | 2021-06-09 5:41 pm | N/A 2031-06-01 | PMV Pharmaceuticals Inc. | PMVP | Thompson Peter A. Director 10% Owner | 16,333 | $0 | 16,333 (Direct) | View |
| 2021-03-30 Conversion | 2021-03-31 7:11 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 25,732,796 | $0 | 13,359,456 (Indirect) | View |
Ownership | 2021-03-25 9:40 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 0 | $0 | 13,319,680 (Indirect) | View |